Cerebral Infarction  >>  Activase (alteplase)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
NCT00147316: Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Completed
3
103
Japan
Alteplase
Mitsubishi Tanabe Pharma Corporation, Kyowa Hakko Kogyo Co., Ltd.
Cerebral Infarction, Brain Ischemia
 
09/03

Download Options